Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2014 03:00 ET | Source: OnCore Biopharma, Inc.

OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection

OnCore Secures Exclusive Worldwide Rights to NVP018 NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...
September 05, 2014 07:00 ET | Source: OnCore Biopharma, Inc.

OnCore Biopharma Closes Series R Financing

Funds to Expand OnCore's Portfolio of Oral Therapeutics for the Treatment of Chronic HBV OnCore to Advance HBV Compounds Into Phase 1 Clinical Development During 2015 Former Pharmasset Team...